Cargando…

Inhibition of Heat Inactivation of Reverse Transcriptase of Human Immunodeficiency Virus Type 1 by Seropositive Sera

The reverse transcriptase (RT) activity of a lysate of human immunodeficiency virus type 1 (HIV) was almost completely inactivated by incubation at 56°C for 20—‐30 min. The heat‐inactivation of RT in the virus lysate or purified RT was partially inhibited in the presence of some human sera or plasma...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nagumo, Toshiyuki, Takeuchi, Yasuhiro, Hoshino, Hiroo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 1992
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5918888/ https://www.ncbi.nlm.nih.gov/pubmed/1379577 http://dx.doi.org/10.1111/j.1349-7006.1992.tb00131.x

Ejemplares similares

HEPARIN INHIBITS INFECTIVITY OF HUMAN IMMUNODEFICIENCY VIRUS IN VITRO
por: Nagumo, Toshiyuki, et al.
Publicado: (1988)

Inhibition of Avian Myeloblastosis Virus Reverse Transcriptase by Aurochloric Acid
por: Semba, Mari, et al.
Publicado: (1990)

Variation of Human Immunodeficiency Virus Type-1 Reverse Transcriptase within the Simian Immunodeficiency Virus Genome of RT-SHIV
por: Wadford, Debra A., et al.
Publicado: (2014)

Anti-feline immunodeficiency virus reverse transcriptase properties of some medicinal and edible mushrooms
por: Seetaha, Supaphorn, et al.
Publicado: (2020)

Click Chemistry-Based Two-Component System for Efficient Inhibition of Human Immunodeficiency Virus (HIV) Reverse Transcriptase (RT)
por: Ledezma, Carlos E., et al.
Publicado: (2020)

Selection of primer-template sequences that bind human immunodeficiency virus reverse transcriptase with high affinity
por: DeStefano, Jeffrey J., et al.
Publicado: (2006)

Ribonucleoside Triphosphates as Substrate of Human Immunodeficiency Virus Type 1 Reverse Transcriptase in Human Macrophages
por: Kennedy, Edward M., et al.
Publicado: (2010)

HuR interacts with human immunodeficiency virus type 1 reverse transcriptase, and modulates reverse transcription in infected cells
por: Lemay, Julie, et al.
Publicado: (2008)

Computational drug design strategies applied to the modelling of human immunodeficiency virus-1 reverse transcriptase inhibitors
por: Santos, Lucianna Helene, et al.
Publicado: (2015)

Biochemical and structural comparisons of non-nucleoside reverse transcriptase inhibitors against feline and human immunodeficiency viruses
por: Rattanabunyong, Siriluk, et al.
Publicado: (2023)

Human Immunodeficiency Virus type-1 reverse transcriptase exists as post-translationally modified forms in virions and cells
por: Davis, Adam J, et al.
Publicado: (2008)

Revealing the Mutation Patterns of Drug-Resistant Reverse Transcriptase Variants of Human Immunodeficiency Virus through Proteochemometric Modeling
por: Qiu, Jingxuan, et al.
Publicado: (2021)

The Y271 and I274 Amino Acids in Reverse Transcriptase of Human Immunodeficiency Virus-1 Are Critical to Protein Stability
por: Zhang, Hao-Jie, et al.
Publicado: (2009)

Mutations in the Reverse Transcriptase and Protease Genes of Human Immunodeficiency Virus-1 from Antiretroviral Naïve and Treated Pediatric Patients
por: Bure, Dinesh, et al.
Publicado: (2015)

Valproic Acid Inhibits the Release of Soluble CD40L Induced by Non-Nucleoside Reverse Transcriptase Inhibitors in Human Immunodeficiency Virus Infected Individuals
por: Davidson, Donna C., et al.
Publicado: (2013)

Impact of human immunodeficiency virus type 1 ribonuclease H inhibitors on the polymerase and RNase H function of foamy virus reverse transcriptase
por: Corona, Angela, et al.
Publicado: (2013)

Meningitis caused by Rhodotorula mucilaginosa in human immunodeficiency virus seropositive patient
por: Baradkar, V. P., et al.
Publicado: (2008)

Fertility Treatment in Couples with Seropositivity for Human Immunodeficiency Virus: Ethics Opinion
Publicado: (2018)

Neutralizing Antibody to Vesicular Stomatitis Virus (HTLV‐I) Pseudotype in Infants Born to Seropositive Mothers
por: Iwahara, Yoshihito, et al.
Publicado: (1993)

Selective killing of human immunodeficiency virus infected cells by non-nucleoside reverse transcriptase inhibitor-induced activation of HIV protease
por: Jochmans, Dirk, et al.
Publicado: (2010)

Intrapatient Evolutionary Dynamics of Human Immunodeficiency Virus Type 1 in Individuals Undergoing Alternative Treatment Strategies with Reverse Transcriptase Inhibitors
por: Kayondo, Jonathan K., et al.
Publicado: (2015)

Indolylarylsulfones, a fascinating story of highly potent human immunodeficiency virus type 1 non-nucleoside reverse transcriptase inhibitors
por: Famiglini, Valeria, et al.
Publicado: (2018)

Telomerase Reverse Transcriptase Regulates microRNAs
por: Lassmann, Timo, et al.
Publicado: (2015)

Heat-Inactivation of Fetal and Newborn Sera Did Not Impair the Expansion and Scaffold Engineering Potentials of Fibroblasts
por: Pellerin, Félix-Antoine, et al.
Publicado: (2021)

Biochemical, inhibition and inhibitor resistance studies of xenotropic murine leukemia virus-related virus reverse transcriptase
por: Ndongwe, Tanyaradzwa P., et al.
Publicado: (2012)

Endothelial Hyper-Permeability Induced by T1D Sera Can be Reversed by iNOS Inactivation
por: Cazzaniga, Alessandra, et al.
Publicado: (2020)

A reverse transcriptase ribozyme
por: Samanta, Biswajit, et al.
Publicado: (2017)

PCR inhibition by reverse transcriptase leads to an overestimation of amplification efficiency
por: Suslov, Oleg, et al.
Publicado: (2005)

Structural and Functional Aspects of Foamy Virus Protease-Reverse Transcriptase
por: Wöhrl, Birgitta M.
Publicado: (2019)

Reverse transcriptase activity in psoriatic lesions: effects of reverse transcriptase inhibitors on keratinocyte proliferation and differentiation
por: Molès, Jean-Pierre, et al.
Publicado: (2009)

Crusted Scabies: Presenting as erythroderma in a human immunodeficiency virus-seropositive patient
por: Kulkarni, Shruti, et al.
Publicado: (2016)

Expression of telomerase reverse transcriptase in peripheral T‐cell lymphoma
por: Arakawa, Fumiko, et al.
Publicado: (2021)

Kidney Disease in Human Immunodeficiency Virus-seropositive Patients: Absence of Human Immunodeficiency Virus-associated Nephropathy was a Characteristic Feature
por: Prakash, J., et al.
Publicado: (2017)

Low rates of nucleoside reverse transcriptase inhibitor and nonnucleoside reverse transcriptase inhibitor drug resistance in Botswana
por: Moyo, Sikhulile, et al.
Publicado: (2019)

Synthesis and anti-human immunodeficiency virus activity of substituted (o,o-difluorophenyl)-linked-pyrimidines as potent non‐nucleoside reverse transcriptase inhibitors
por: Čechová, Lucie, et al.
Publicado: (2019)

Structural Aspects of Drug Resistance and Inhibition of HIV-1 Reverse Transcriptase
por: Singh, Kamalendra, et al.
Publicado: (2010)

Endogenous Reverse Transcriptase Inhibition Attenuates TLR5-Mediated Inflammation
por: Dopkins, Nicholas, et al.
Publicado: (2023)

Molecular Detection and Identification of Cryptosporidium viatorum in a Human Immunodeficiency Virus-seropositive Patient
por: Khalil, Shehla, et al.
Publicado: (2018)

Biophysical and enzymatic properties of the simian and prototype foamy virus reverse transcriptases
por: Hartl, Maximilian J, et al.
Publicado: (2010)

Differential Binding of Tenofovir and Adefovir to Reverse Transcriptase of Hepatitis B Virus
por: van Hemert, Formijn J., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_0t1uhn2lpfnab5mivc5e2rasv6